New Horizons In Schizophrenia Research

This webinar reviews the latest developments in NIMH-sponsored research including the recently announced Accelerating Medicines Partnership (AMP) Schizophrenia, a public-private partnership to advance the understanding of the risk factors for developing schizophrenia and promising new avenues for treatment.
-
A number of novel treatment strategies for schizophrenia have shown promise, but changes in response have been a major challenge. One way to address this challenge is to identify biomarkers that may predict the course of the illness and assist in the design of clinical trials of new medications that can address the variability in treatment response.
-
Dr. Lisanby reviews exciting developments underway related to large-scale studies focused on identifying biomarkers of related to schizophrenia, with the long-term goal of leading to development of effective treatments and prevention strategies individualized for the needs of each person.
-
To learn more about NAMI’s Ask the Expert webinar series, view older recordings and to register for future webinars, visit: www.nami.org/B...
-
If you or a loved one is seeking mental health treatment or additional information on mental health:
• Visit our website at NAMI.org.
• Call our HelpLine at 1-800-950-NAMI (6264) or text “HELPLINE” to 62640, open Mon-Fri from 10 a.m. to 10 p.m.
• Find your local NAMI at nami.org/findsupport
• If you or a loved one is experiencing a crisis, please call or text 988, available 24/7
-
NAMI, the National Alliance on Mental Illness, is the nation’s largest grassroots mental health organization dedicated to building better lives for the millions of Americans affected by mental illness.